Publications by authors named "Won Seog Kim"

100Publications

Real-world data on the survival outcome of patients with newly diagnosed Waldenström macroglobulinemia.

Korean J Intern Med 2020 Aug 14. Epub 2020 Aug 14.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3904/kjim.2019.367DOI Listing
August 2020

Immune checkpoint inhibitors in patients with pretreated HodgkinÊs lymphoma: a Korean single-center, retrospective study.

Blood Res 2020 Jun;55(2):85-90

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5045/br.2020.2020014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343550PMC
June 2020

Efficacy of intravenous iron treatment for chemotherapy-induced anemia: A prospective Phase II pilot clinical trial in South Korea.

PLoS Med 2020 06 8;17(6):e1003091. Epub 2020 Jun 8.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University of School of Medicine, Seoul, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pmed.1003091DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279571PMC
June 2020

A comprehensive analysis of adult patients with secondary hemophagocytic lymphohistiocytosis: a prospective cohort study.

Ann Hematol 2020 Sep 21;99(9):2095-2104. Epub 2020 May 21.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro Gangnam-gu, Seoul, 06351, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-020-04083-6DOI Listing
September 2020

Plasma cell-free DNA is a prognostic biomarker for survival in patients with aggressive non-Hodgkin lymphomas.

Ann Hematol 2020 Jun 15;99(6):1293-1302. Epub 2020 Apr 15.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-020-04008-3DOI Listing
June 2020

Comparison of the Lymph2Cx Assay and Hans Algorithm in Determining the Cell-of-Origin of Diffuse Large B-Cell Lymphomas, Not Otherwise Specified.

Appl Immunohistochem Mol Morphol 2020 Apr 13. Epub 2020 Apr 13.

Department of Pathology and Translational Genomics, Samsung Medical Center.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAI.0000000000000843DOI Listing
April 2020

Treatment of mantle cell lymphoma in Asia: a consensus paper from the Asian Lymphoma Study Group.

J Hematol Oncol 2020 03 17;13(1):21. Epub 2020 Mar 17.

School of Medicine, Sungkyunkwan University, Samsung Medical Center 115 Irown-Ro, Gangnam-Gu, Seoul, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13045-020-00855-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079508PMC
March 2020

Association between sexuality knowledge and sexual dysfunction in hematopoietic stem cell transplantation patients and their partners.

Patient Educ Couns 2020 08 7;103(8):1630-1636. Epub 2020 Mar 7.

Cancer Education Center, Samsung Comprehensive Cancer Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea; Department of Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University, Seoul, South Korea; Center for Clinical Epidemiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea; Departments of Epidemiology and Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pec.2020.03.007DOI Listing
August 2020

Pre-treatment serum IL-10 predicts the risk of secondary central nervous system involvement in patients with diffuse large B-cell lymphoma.

Cytokine 2020 May 2;129:155048. Epub 2020 Mar 2.

Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cyto.2020.155048DOI Listing
May 2020

Serum levels of soluble programmed death-ligand 1 (sPD-L1) in patients with primary central nervous system diffuse large B-cell lymphoma.

BMC Cancer 2020 Feb 13;20(1):120. Epub 2020 Feb 13.

Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-020-6612-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020571PMC
February 2020

Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study in multiple populations.

Lancet Oncol 2020 02 23;21(2):306-316. Epub 2019 Dec 23.

Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China; Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Center for Precision Medicine, Sun Yat-sen University, Guangzhou, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(19)30799-5DOI Listing
February 2020

Asian variant of intravascular large B-cell lymphoma: a comparison of clinical features based on involvement of the central nervous system.

Korean J Intern Med 2020 07 25;35(4):946-956. Epub 2019 Nov 25.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3904/kjim.2018.396DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373974PMC
July 2020

Ruxolitinib shows activity against Hodgkin lymphoma but not primary mediastinal large B-cell lymphoma.

BMC Cancer 2019 Nov 10;19(1):1080. Epub 2019 Nov 10.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-019-6303-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6842512PMC
November 2019

Impact of fear of cancer recurrence on survival among lymphoma patients.

Psychooncology 2020 02 6;29(2):364-372. Epub 2020 Jan 6.

Department of Clinical Research Design and Evaluation, Samsung Advanced Institute for Health Science and Technology, School of Medicine, Sungkyunkwan University, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pon.5265DOI Listing
February 2020

Immune subtyping of extranodal NK/T-cell lymphoma: a new biomarker and an immune shift during disease progression.

Mod Pathol 2020 04 25;33(4):603-615. Epub 2019 Oct 25.

Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41379-019-0392-8DOI Listing
April 2020

Interleukin-6 mediates resistance to PI3K-pathway-targeted therapy in lymphoma.

BMC Cancer 2019 Oct 10;19(1):936. Epub 2019 Oct 10.

Research Institute for Future Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 06351, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-019-6057-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785854PMC
October 2019

Multicenter retrospective analysis of the clinicopathologic features of monomorphic epitheliotropic intestinal T-cell lymphoma.

Ann Hematol 2019 Nov 6;98(11):2541-2550. Epub 2019 Sep 6.

Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-dong, Gangnam-gu, Seoul, 06351, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-019-03791-yDOI Listing
November 2019

The Glasgow Prognostic Score is a significant predictor of peripheral T-cell lymphoma (PTCL) treated with CHOP-based chemotherapy and comparable with PTCL prognostic scores.

Int J Hematol 2019 Oct 27;110(4):438-446. Epub 2019 Jun 27.

Department of Internal Medicine, Dong-A University College of Medicine, 26 Daeshingongwon-ro, Seo-gu, Busan, 49201, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-019-02693-zDOI Listing
October 2019

A phase II trial of bendamustine, carboplatin, and dexamethasone for refractory or relapsed peripheral T-cell lymphoma (BENCART trial).

Leuk Lymphoma 2019 12 6;60(13):3251-3257. Epub 2019 Jun 6.

Department of Pathology, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1622100DOI Listing
December 2019

Real world data on follicular lymphoma patients treated by rituximab-containing immunochemotherapy and rituximab maintenance.

Korean J Intern Med 2020 01 4;35(1):194-204. Epub 2019 Apr 4.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3904/kjim.2018.196DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6960034PMC
January 2020

Analysis of circulating tumor DNA by targeted ultra-deep sequencing across various non-Hodgkin lymphoma subtypes.

Leuk Lymphoma 2019 09 18;60(9):2237-2246. Epub 2019 Feb 18.

Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine , Seoul , Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1573998DOI Listing
September 2019

Multicenter Phase 2 Study of Reduced-Dose CHOP Chemotherapy Combined With Rituximab for Elderly Patients With Diffuse Large B-Cell Lymphoma.

Clin Lymphoma Myeloma Leuk 2019 03 12;19(3):149-156. Epub 2018 Nov 12.

Division of Hematology-Oncology, Department of Internal Medicine, School of Medicine, Medical Research Institute, Pusan National University Hospital, Busan, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2018.11.003DOI Listing
March 2019

Treatment of localized extranodal NK/T cell lymphoma, nasal type: a systematic review.

J Hematol Oncol 2018 12 20;11(1):140. Epub 2018 Dec 20.

Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-dong, Gangnam-gu, Seoul, 135-710, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13045-018-0687-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300911PMC
December 2018

Vitamin D deficiency is associated with inferior survival of patients with extranodal natural killer/T-cell lymphoma.

Cancer Sci 2018 Dec 28;109(12):3971-3980. Epub 2018 Nov 28.

Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/cas.13844
Publisher Site
http://dx.doi.org/10.1111/cas.13844DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6272114PMC
December 2018

Profiles of serum cytokines and their clinical implications in patients with peripheral T-cell lymphoma.

Cytokine 2019 01 14;113:371-379. Epub 2018 Oct 14.

Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, Republic of Korea; Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cyto.2018.10.009DOI Listing
January 2019

Validation of the Marginal Zone Lymphoma International Prognostic Index.

Ann Hematol 2019 Feb 11;98(2):457-464. Epub 2018 Oct 11.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, School of Medicine, Sungkyunkwan Universitye, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, South Korea.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00277-018-3516-1
Publisher Site
http://dx.doi.org/10.1007/s00277-018-3516-1DOI Listing
February 2019

The cell-of-origin classification of diffuse large B cell lymphoma in a Korean population by the Lymph2Cx assay and its correlation with immunohistochemical algorithms.

Ann Hematol 2018 Dec 1;97(12):2363-2372. Epub 2018 Aug 1.

Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-018-3442-2DOI Listing
December 2018

Allogeneic Stem Cell Transplantation for Patients with Natural Killer/T Cell Lymphoid Malignancy: A Multicenter Analysis Comparing Upfront and Salvage Transplantation.

Biol Blood Marrow Transplant 2018 12 29;24(12):2471-2478. Epub 2018 Jul 29.

Department of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; Department of Medical Device Management & Research, SAIHST, Sungkyunkwan University, Seoul, Republic of Korea; Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.07.034DOI Listing
December 2018

Comparison of Efficacy of Pembrolizumab between Epstein-Barr Virus‒Positive and ‒Negative Relapsed or Refractory Non-Hodgkin Lymphomas.

Cancer Res Treat 2019 Apr 20;51(2):611-622. Epub 2018 Jul 20.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4143/crt.2018.191DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473267PMC
April 2019

Radiation Therapy Outcome and Clinical Features of Duodenal-Type Follicular Lymphoma.

Cancer Res Treat 2019 Apr 10;51(2):547-555. Epub 2018 Jul 10.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4143/crt.2018.190DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473297PMC
April 2019

Serum IL18 is associated with hemophagocytosis and poor survival in extranodal natural killer/T-cell lymphoma.

Leuk Lymphoma 2019 02 6;60(2):317-325. Epub 2018 Jul 6.

a Department of Medicine, Division of Hematology-Oncology , Samsung Medical Center, Sungkyunkwan University School of Medicine , Seoul , Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2018.1480772DOI Listing
February 2019

Treating synchronous bilateral ocular adnexal marginal zone lymphoma: the consortium for improving survival of lymphoma study.

Ann Hematol 2018 Oct 11;97(10):1851-1857. Epub 2018 Jun 11.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-018-3387-5DOI Listing
October 2018

Targeted deep sequencing of gastric marginal zone lymphoma identified alterations of TRAF3 and TNFAIP3 that were mutually exclusive for MALT1 rearrangement.

Mod Pathol 2018 09 15;31(9):1418-1428. Epub 2018 May 15.

Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41379-018-0064-0DOI Listing
September 2018

Significance of circulating Epstein-Barr virus DNA monitoring after remission in patients with extranodal natural killer T cell lymphoma.

Ann Hematol 2018 Aug 8;97(8):1427-1436. Epub 2018 Apr 8.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-018-3313-xDOI Listing
August 2018

Bendamustine plus rituximab for relapsed or refractory diffuse large B cell lymphoma: a multicenter retrospective analysis.

Ann Hematol 2018 Aug 4;97(8):1437-1443. Epub 2018 Apr 4.

Division of Hematology-Oncology, Department of Medicine, Dongsan Medical Center, Keimyung University School of Medicine, 56, Dalseong-ro Jung-gu, Daegu, 700-712, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-018-3317-6DOI Listing
August 2018

Use of complementary and alternative medicine by lymphoma survivors in South Korea.

Eur J Oncol Nurs 2018 Apr 20;33:91-96. Epub 2018 Feb 20.

Division of Hematology-Oncology, Inha University Hospital and College of Medicine, Incheon, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejon.2018.01.012DOI Listing
April 2018

Phase I study of CKD-581, a pan-histone deacetylase inhibitor, in patients with lymphoma or multiple myeloma refractory to standard therapy.

Invest New Drugs 2018 10 9;36(5):877-885. Epub 2018 Mar 9.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-018-0582-0DOI Listing
October 2018

CXCR4 can induce PI3Kδ inhibitor resistance in ABC DLBCL.

Blood Cancer J 2018 02 22;8(2):23. Epub 2018 Feb 22.

Research Institute for Future Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 06351, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41408-018-0056-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823878PMC
February 2018

Satisfaction with sexual activity and sexual dysfunction in hematopoietic stem cell transplantation survivors and their partners: a couple study.

Bone Marrow Transplant 2018 08 5;53(8):967-976. Epub 2018 Feb 5.

Department of Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University, Seoul, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-018-0097-5DOI Listing
August 2018

Brentuximab vedotin: clinical updates and practical guidance.

Blood Res 2017 Dec 26;52(4):243-253. Epub 2017 Dec 26.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5045/br.2017.52.4.243DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762734PMC
December 2017

Recent advances in understanding and managing T-cell lymphoma.

F1000Res 2017 12;6:2123. Epub 2017 Dec 12.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine , Seoul, Korea, South.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12688/f1000research.12573.1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728196PMC
December 2017

Identification of T-cell receptor expression in EBV-positive neoplastic cells in extranodal NK/T-cell lymphoma, nasal-type, and comparison with T-cell receptor gene rearrangement by BIOMED-2 assay.

Hum Pathol 2018 03 16;73:51-58. Epub 2017 Dec 16.

Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University, 06351, Seoul, Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2017.12.006DOI Listing
March 2018

Health-Related Quality of Life in Non-Hodgkin Lymphoma Survivors: A Prospective Cohort Study.

Cancer Res Treat 2018 Oct 9;50(4):1051-1063. Epub 2017 Nov 9.

Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4143/crt.2017.207DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192930PMC
October 2018

Elevated serum interleukin-10 level and M2 macrophage infiltration are associated with poor survival in angioimmunoblastic T-cell lymphoma.

Oncotarget 2017 Sep 17;8(44):76231-76240. Epub 2017 Jul 17.

Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.19301DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652701PMC
September 2017

Clinical impact of CD5 expression in Korean patients with diffuse large B-cell lymphoma.

Blood Res 2017 Sep 25;52(3):193-199. Epub 2017 Sep 25.

Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5045/br.2017.52.3.193DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641511PMC
September 2017

Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma.

J Clin Oncol 2017 Dec 4;35(35):3898-3905. Epub 2017 Oct 4.

Martin Dreyling, Ludwig Maximilians University of Munich, Munich; Georg Lenz, University Hospital Münster, Münster; Marius Giurescu, Karl Köchert, Henrik Seidel, and Florian Hiemeyer, Bayer AG, Berlin, Germany; Armando Santoro, Humanitas Clinical and Research Center, Rozzano; Pier Luigi Zinzani, University of Bologna, Bologna, Italy; Luigina Mollica, Hôpital Maisonneuve-Rosemont, Montreal, Quebec, Canada; Sirpa Leppä, Helsinki University Central Hospital Cancer Center, Helsinki, Finland; George A. Follows, Addenbrooke's Hospital, Cambridge, United Kingdom; Won Seog Kim, Samsung Medical Center, Seoul, South Korea; Arnon Nagler, Tel Aviv University, Tel HaShomer, Israel; Panayiotis Panayiotidis, National and Kapodistrian University of Athens, Athens, Greece; Judit Demeter, Semmelweis University, Budapest, Hungary; Muhit Özcan, Ankara University School of Medicine, Ankara, Turkey; Marina Kosinova, Kemerovo Regional Clinical Hospital, Kemerovo, Russian Federation; Krimo Bouabdallah, University Hospital of Bordeaux, Pessac; Franck Morschhauser, Hôpital Claude Huriez, Lille, France; Don A. Stevens, Norton Cancer Institute, Louisville, KY; David Trevarthen, Comprehensive Cancer Care and Research Institute of Colorado, Englewood, CO; and Lisa Cupit, Li Liu, Carol Peña, Shuxin Yin, Jose Garcia-Vargas, and Barrett H. Childs, Bayer HealthCare Pharmaceuticals, Whippany, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.4648DOI Listing
December 2017

Whole brain radiation dose reduction for primary central nervous system lymphoma patients who achieved partial response after high-dose methotrexate based chemotherapy.

Jpn J Clin Oncol 2017 11;47(11):995-1001

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyx120DOI Listing
November 2017

Clinical features and treatment outcomes of blastic plasmacytoid dendritic cell neoplasm: a single-center experience in Korea.

Korean J Intern Med 2017 Sep 18;32(5):890-899. Epub 2017 Aug 18.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3904/kjim.2015.406DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583450PMC
September 2017

Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma.

J Clin Oncol 2017 Nov 10;35(31):3529-3537. Epub 2017 Aug 10.

Umberto Vitolo, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Turin; Angelo Michele Carella, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Azienda Ospedaliera e Universitaria San Martino-IST, Genoa; Antonio Pinto, Istituto Nazionale Tumori, Fondazione G. Pascale, IRCCS, Naples; Maurizio Martelli, Sapienza University, Rome, Italy; Marek Trněný, Charles University, General Hospital, Prague; David Belada, Charles University Hospital, Hradec Králové, Czech Republic; John M. Burke, Rocky Mountain Cancer Centers, Aurora, CO; US Oncology Research, The Woodlands, TX; Neil Chua, Cross Cancer Institute, University of Alberta, Edmonton, Alberta; Laurie H. Sehn, British Columbia Cancer Agency and the University of British Columbia, Vancouver, British Columbia, Canada; Pau Abrisqueta, University Hospital Vall d'Hebron, Barcelona, Spain; Judit Demeter, Semmelweiss University, Budapest, Hungary; Ian Flinn, Sarah Cannon Research Institute; Tennessee Oncology, Nashville, TN; Xiaonan Hong, Fudan University Shanghai Cancer Center, Shanghai; Yuan-Kai Shi, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, China; Won Seog Kim, Samsung Medical Center, Sunkyunkwan University School of Medicine, Seoul, Republic of Korea; Yoichi Tatsumi, Kinki University Hospital, Osaka, Japan; Mikkel Z. Oestergaard, Günter Fingerle-Rowson, Olivier Catalani, and Tina Nielsen, F. Hoffman-La Roche, Basel, Switzerland; and Michael Wenger, Genentech, South San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.73.3402DOI Listing
November 2017

Low-Dose Radiation Therapy for Primary Conjunctival Marginal Zone B-Cell Lymphoma.

Cancer Res Treat 2018 Apr 16;50(2):575-581. Epub 2017 Jun 16.

Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4143/crt.2017.182DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5912130PMC
April 2018

Atypical presentations of MERS-CoV infection in immunocompromised hosts.

J Infect Chemother 2017 Nov 23;23(11):769-773. Epub 2017 May 23.

Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 135-710, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jiac.2017.04.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129274PMC
November 2017

IRF4/MUM1 expression is associated with poor survival outcomes in patients with peripheral T-cell lymphoma.

J Cancer 2017 29;8(6):1018-1024. Epub 2017 Mar 29.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://www.jcancer.org/v08p1018.htm
Publisher Site
http://dx.doi.org/10.7150/jca.17358DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436254PMC
March 2017

Looking to the future and learning lessons from the recent past: changing stakeholder perceptions of biosimilars in cancer.

Future Oncol 2017 May;13(15s):17-29

CELLTRION Healthcare Co. Ltd, Incheon, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2017-0154DOI Listing
May 2017

Clinical development of CT-P10 and other biosimilar cancer therapeutics.

Future Oncol 2017 May;13(15s):31-44

CELLTRION Healthcare Co. Ltd, Incheon, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2017-0155DOI Listing
May 2017

Cell-of-origin of diffuse large B-cell lymphomas determined by the Lymph2Cx assay: better prognostic indicator than Hans algorithm.

Oncotarget 2017 Mar;8(13):22014-22022

Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.15782DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400642PMC
March 2017

The Consortium for Improving Survival of Lymphoma (CISL): recent achievements and future perspective.

Blood Res 2017 Mar 27;52(1):3-6. Epub 2017 Mar 27.

Division of Hematology/Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5045/br.2017.52.1.3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5383584PMC
March 2017

Validation of the Korean Version of the Quality of Life-Cancer Survivors (QOL-CS-K) Questionnaire in Lymphoma Survivors.

Cancer Res Treat 2018 Jan 30;50(1):204-211. Epub 2017 Mar 30.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://www.e-crt.org/journal/view.php?doi=10.4143/crt.2017.0
Publisher Site
http://dx.doi.org/10.4143/crt.2017.091DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784625PMC
January 2018

Patient-Generated Subjective Global Assessment as a prognosis tool in patients with multiple myeloma.

Nutrition 2017 Apr 25;36:67-71. Epub 2016 Jun 25.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nut.2016.06.009DOI Listing
April 2017

Clinical impact of serum survivin positivity and tissue expression of EBV-encoded RNA in diffuse large B-cell lymphoma patients treated with rituximab-CHOP.

Oncotarget 2017 Feb;8(8):13782-13791

Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.14636DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355138PMC
February 2017

Epstein-Barr virus EBNA2 directs doxorubicin resistance of B cell lymphoma through CCL3 and CCL4-mediated activation of NF-κB and Btk.

Oncotarget 2017 Jan;8(3):5361-5370

Research Institute for Future Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.14243DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354914PMC
January 2017

Serum level of CXCL10 is associated with inflammatory prognostic biomarkers in patients with diffuse large B-cell lymphoma.

Hematol Oncol 2017 Dec 12;35(4):480-486. Epub 2016 Dec 12.

Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2374DOI Listing
December 2017